The Hong Kong Anti-Doping Committee (HKADC) announced today (8 September 2016) that Mr. WAN Hui Kwong, athlete in the sport of Bodybuilding, has been imposed a 4-year sanction and a fine of HK$20,000 for an anti-doping rule violation.
The violation occurred during an in-competition doping control on 12 June 2016 where the athlete’s urine sample was tested positive for Drostanolone metabolite, Clenbuterol, Stanozolol metabolites and Anastrazol. According to the 2016 Prohibited List, Drostanolone, Clenbuterol, Stanozolol and Anastrazol are prohibited in sport at all times.
In response to HKADC’s notification of adverse analytical finding, Mr. WAN waived his right to order the analysis of his B sample. Mr. WAN also waived his right to request for a hearing to be convened. The Doping Control Panel had carefully considered the case and Mr. WAN was found guilty of violating Article 2.1 of the Anti-Doping Rules of HKADC. Mr. WAN’s period of ineligibility started from 8 August 2016 to 7 August 2020. As a result of the anti-doping rule violation, all competitive results achieved by Mr. WAN on 12 June 2016 were disqualified.
During the period of ineligibility, Mr. WAN is ineligible to participate in any capacity in a competition or activity described in Article 10.12.1 of the Anti-Doping Rules of HKADC.
HKADC, under the auspices of the SF&OC, is an independent committee responsible for the anti-doping programme in Hong Kong. HKADC is committed to preserve a doping-free environment for fair play in sport in Hong Kong.